Induction of cytochrome P450 isoforms, specifically CYP1A1, and their catalytic activities are potential biomarkers of environmental contamination by polychlorinated biphenyls (PCBs). In this study, dogs were exposed to 25 ppm or 5 ppm Aroclor 1248 (PCB mixture) daily in their diet for 10 or 20 weeks, respectively. Relative to controls, hepatic microsomes from dogs dosed with PCBs had higher levels of CYP1A1 detected in immunoblots and higher levels of EROD activity, but low levels of induction for CYP2B and PROD activity. Concentrations of 96 PCB congeners in serum and liver were evaluated using capillary chromatography. Results showed that all dogs exposed to PCB mixtures had higher levels of PCB in serum and liver. Dogs preferentially sequestered highly chlorinated PCB congeners in liver relative to serum. With these experiments, we demonstrated that EROD activity was a potentially sensitive marker of PCB exposure at 5 and 25 ppm. Furthermore, CYP1A1 and EROD activity were maximally induced in dogs consuming dietary concentrations only 2.5 times the maximal permissible level for human food (FDA). The value of CYP1A1 induction as a biomarker of PCB exposure was tenuous because neither CYP1A1 levels nor EROD activity correlated with total PCB body burden. However, a small subset of congeners were identified in liver that may strongly influence EROD and PROD induction. Finally, two dogs in the 25 ppm dose group were fasted for 48 h. After 24 h of fasting, several new congeners appeared in the serum and remained in the serum for the remainder of the fast. The fast caused a 293% increase in PCB concentration in serum. This increase has strong implications regarding mobilization of toxic PCBs in wildlife during fasting (e.g., migration, hibernation).
The Mohawk Nation at Akwesasne is a Native American community located on the St. Lawrence River in New York State and the Canadian provinces of Ontario and Quebec. Akwesasne is in Massena, NY, adjacent to a site included on the National Priority list of the U.S. Environmental Protection Agency (Superfund site). The site is highly contaminated with polychlorinated biphenyls (PCBs); PCB concentrations range up to 4% in soil and sludge on this site (NYS, 1995) . Movement of PCBs to nearby regions of the St. Lawrence River has been documented (RMT, 1986 (RMT, , 1988 . Fadden reviewed several studies that demonstrated extensive PCB contamination in surface water, sediments, and biota at Akwesasne (Fadden, 1994) . PCBs are readily bioaccumulated, and the people of Akwesasne derive a portion of their diet from the local biota (NYS, 1995) . Thus, the people of Akwesasne are exposed to PCBs via diet and environmental dusts (NYS, 1995) and possibly airborne vapors (Casey et al., 1998) .
PCBs are a group of 209 chemically distinct congeners of which approximately 130 have been included in commercial products widely manufactured between 1930 and 1978. PCBs are hydrophobic and persistent in the environment. PCB-induced immunotoxicity and reproductive toxicity has been documented in humans, a wide variety of wildlife, and many domestic and laboratory animals (Dean and Murray, 1991; Fadden, 1994; Golub et al., 1991) . Toxicity is generally thought to correlate with persistence of PCBs, especially highly-chlorinated congeners, in the body (WHO, 1993) . PCBs commonly sequester to adipose and liver tissue.
The cytochrome P450 monooxygenases (P450s) are a superfamily of enzymes; most species possess more than one P450 isoform (Nelson et al., 1993) . P450s may detoxify PCBs or produce more toxic metabolites (Sipes and Gandolfi, 1991) . P450s in dogs and other organisms are reported to metabolize and enhance the elimination of specific PCB congeners (Ariyoshi et al., 1992; Duignan et al., 1988; Sipes et al., 1982) . Certain hepatic P450s are induced by specific PCB congeners. Some congeners bind and agonize the aryl hydrocarbon receptor (AhR), leading to induction of the CYP1A family of P450s including CYP1A1 (Hankinson, 1995) , which possesses ethoxyresorufin-O-deethylase (EROD) activity (Drahushuk et al., 1996; Moorthy et al., 1997; Santostefano et al., 1996; Sinal and Bend, 1996) . Other congeners primarily induce the CYP2B family of enzymes, which possesses pentoxyresorufin-O-depentylase (PROD) activity in mammals (Burke et al., 1985; Correia, 1995) . Some congeners, called "mixed" inducers, induce both EROD and PROD activities. High levels of CYP1A1 and EROD activity may indicate exposure to PCBs. Several authors recommend using the induction of P450s, particularly CYP1A1, as a bioindicator of environmental contamination with PCBs or polyaromatic hydrocarbons (Lindstrom-Seppa et al., 1994; Rattner et al., 1993; White et al., 1994; Yawetz et al., 1997) .
Domestic dogs may be an excellent sentinel species or biomarker for PCB contamination (Fadden, 1994; Fadden and Quimby, 1994; Shilling et al., 1988) , particularly at Akwesasne. Dogs live in a close social position with humans, have long life spans and share a similar physical environment as humans (Bukowski and Wartenberg, 1997; Fadden, 1994; Glickman and Domanski, 1986; NRC, 1991; Shifrine and Wilson, 1980) . Also, domestic dogs are given a regimented diet but are not exposed to confounding factors for epidemiological studies (i.e., occupational toxicants, smoking, alcohol abuse, and drug abuse) (Fadden, 1994) . Previously, laboratory studies showed that PCB exposure in dogs caused immunologic abnormalities similar to those found in dogs living at Akwesasne (Cohen et al., 1997; Fadden, 1994; Fadden et al., 1997; Fadden and Quimby, 1993; 1994) .
This study is a subset of 19 tests designed to determine the effects of PCB exposure on dogs and to evaluate various potential biomarkers of PCB exposure to dogs. In this study, we examined the induction of CYP1A1, and CYP2B1/2 (by immunoblotting), in addition to EROD and PROD activities in dogs exposed daily to either 5 or 25 ppm of Aroclor 1248 in their diet. The results are discussed in light of the 18 other tests used to identify biomarkers of PCB exposure in dogs. We also examined the congener profiles in the liver and serum of some of the dogs to understand better the sequestration of PCBs in the animals and the effects of certain PCBs on the induction of P450s. Additionally, we examined the effects of fasting on the congener profiles in serum in a subset of animals.
MATERIALS AND METHODS
Animals. Twenty purpose-bred mongrels, 12-15 months of age, weighing 12-27 kg, were divided among three groups; half the animals in groups A and B were males. All dogs were purchased from a class A USDA-registered vendor and maintained in AAALAC accredited facilities. All dogs fed PCBs received Aroclor 1248 (Chem Service Inc., Westchester, PA) dissolved in corn oil. Group A (n ϭ 8) received the vehicle alone for 20 weeks. Group B (n ϭ 7) received a daily dose of 5 ppm PCB for 20 weeks. Group C (n ϭ 2, males) received 25 ppm PCB daily for 10 weeks, after which PCBs were withdrawn. A pre-exposure dog feed trial indicated the average amount of feed consumed per kg of dog body weight. To achieve 5 and 25 ppm Aroclor 1248 in the diet, gelatin capsules containing corn oil alone or corn oil with dissolved PCB were fed to each dog as they received their morning ration (at 7:30 A.M.). Capsules were charged with 0.4 or 2 mg of PCB (corresponding to 5 or 25 ppm in the diet, respectively) by removing the appropriate volume from a stock PCB-corn oil mixture. The 24-h allocation of feed was pre-measured and placed in feeders for each dog; most of this feed was consumed during the first 30 min of the 8-h feeding period. Capsules were covered with a small amount of canned dogfood (Big Red, Agway Corp., Syracuse, NY) and eaten by dogs along with their dry ration (Pro Lab 2000, Agway Corp., Syracuse, NY). The Pro Lab 2000 ration contained less than 25 ppb PCB. Body weights were taken on each dog weekly and the amount of feed and PCB in corn oil, adjusted accordingly. During this trial, systemic toxicity was not observed, as characterized by serum clinical chemistry determination (20 analytes) and percent change in body weight. No signs of inappetence were observed during the trial.
Sample collection. At the completion of the 20 week trial, ten ml of blood was drawn from each dog and the blood was allowed to clot at 25°C for 2 h. Serum was aspirated from the top of a centrifuged blood sample (800 g for 10 min), transferred to hexane-washed glass vials and frozen at Ϫ80°C until used. Then each dog was euthanized with an overdose of sodium pentobarbital administered intravenously. Approximately 10 g of liver were immediately prepared for isolation of microsomes and another 5-g portion was frozen in a hexane washed glass vial at Ϫ80°C for quantification of PCBs. Blood was also drawn as described above in two dogs in Group C on week 12; samples were collected prior to a fast and at 24-h intervals during a 48-h fast.
Chemicals and materials. All chemicals and solvents were purchased from either Sigma Chemical Company (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA) unless otherwise noted. Dr. J. Rinninger (Paracelsian Labs, Ithaca, NY), generously donated goat polyclonal antisera that reacts with CYP1A1 and CYP1A2 from rat (Gentest, Woburn, MA), goat polyclonal antibody that reacts with CYP2B1/2 (Gentest), and a sample of rat liver S9. The S9 fraction was from a male Sprague-Dawley rat sacrificed 5 days after a single dose of 500 mg/kg of Aroclor 1254.
Microsome preparation. Liver tissue from each dog was briefly rinsed in homogenization buffer (10% glycerol, 1 mM EDTA, 0.1 mM dithiothreitol, 1 mM phenylmethyl sulfonyl fluoride, 1 mM phenylthiocarbamide, 0.1 M sodium phosphate, pH 7.5) (Lee and Scott, 1989) , flash frozen in liquid nitrogen, and stored at Ϫ70°C. Samples were thawed on ice and the following steps were completed on ice or at 4°C. The tissues were homogenized in the above buffer (1 g tissue/4 ml buffer) in a glass/Teflon homogenizer by 8 strokes of a motorized homogenizer (Caframo, Wiarton, Ontario). The homogenate was centrifuged for 20 min at 10,000 g (13,000 rpm) in a JA-20 rotor with a Beckman (Fullerton, CA) J-21C centrifuge. The supernatant was centrifuged for 60 min at 100,000 g (37,000 rpm) in a Beckman 70-ti rotor with a Beckman L8-M ultra-centrifuge. The resulting pellet of microsomes was resuspended in 0.5 ml resuspension buffer (20% glycerol, 1 mM EDTA, 0.1 mM dithiothreitol, 1 mM phenylmethyl sulfonyl fluoride, 0.1 M sodium phosphate, pH 7.5) (Lee and Scott, 1989) . These samples were stored at Ϫ70°C. Protein concentration was quantified using Bio-Rad Protein Reagent (Hercules, CA) and a Beckman DU-50 spectrophotometer with bovine serum albumin as a standard.
SDS polyacrylamide gel electrophoresis and immunoblotting. The proteins of the microsomes and S9 sample (15 mg protein each lane) were separated with a 1.5 mm thick acrylamide gel (Laemmli, 1970 ) using a 30 mA constant current. The stacking and running gels were 4% and 10% acrylamide, respectively. Protein standards were from BioRad (Hercules, CA). The separated proteins were transferred from the gel to nitrocellulose (BioRad) (Kao et al., 1986) . The immunoblots were processed with a VectaStain Elite ABCperoxidase kit (Vector Laboratories, Burlingame, CA) using the goat polyclonal antibodies. Relative intensities of the bands were determined using Adobe Photoshop 3.0.5 from a digital photo from a DC 84650 Kodak camera. Three separate measurements of each band were averaged and compared to the lightest band to calculate a relative intensity of staining. The immunoblotting procedure was repeated three times with similar relative levels of staining for each band.
Fluorometric assays. Ethoxyresorufin O-demethylase (EROD) and pentoxyresorufin O-depentylation (PROD) activities of the liver microsomes were measured using an Aminco SPF-500 spectrofluorometer (American Instrument Company, Silver Spring, MD) with the following settings: 530 nm excitation wavelength (4-nm slit width), 580 nm emission wavelength (0.5-nm slit width), 1.0 range, and 10 damping. Each assay sample comprised 0.1 mg protein in 25 l resuspension buffer, 1.961 l buffer (0.1 mM EDTA, 5 mM MgCl 2 , 0.1 M potassium phosphate, pH 7.8), 4 l 1-mM substrate in dimethyl sulfoxide, and 10 l 0.01-M NADPH (Mayer et al., 1977; Wheelock and Scott, 1992) . Each sample was assayed for 2 minutes prior to the addition of NADPH to verify that there was no background activity. After the addition of NADPH, each sample was assayed for 5 minutes to determine the enzymatic activity. Each individual sample of microsomes was assayed three times. Resorufin was used to develop a standard curve which was used to calculate the production of product in the assay.
Determination of PCB.
The liver and sera were analyzed by congener specific analysis. This was performed by using high resolution gas chromatography (GC) with an electron capture detector (Bush et al., 1983; . Briefly, one gram of tissue was mixed with anhydrous sodium sulfate to remove the water. The tissue and sodium sulfate was then homogenized with 20 ml of hexane:acetone (1:1). The hexane supernatant was then pipetted into a volumetric flask. The extraction was repeated two more times, and the combined extracts were diluted to 50 ml; 2 ml was then removed for a gravimeteric measurement of the percent lipid. The remaining extract was transferred to a Kuderna-Danish evaporator and concentrated to approximately 2 ml on a steam bath, transferring the extract quantitatively to a 1 cm ϫ 15 cm chromatography column containing 10 g of calibrated 4% deactivated Florisil (US Silica, PA) with a 2-g layer of sodium sulfate on top of the Florisil . The sample was then eluted with hexane and 50 ml was collected. The extract was evaporated to 1.0 ml and pipetted into a 2-ml GC vial for analysis.
For the extraction of PCB from serum, the sample was weighed and an equal amount of methanol (in ml) was added. Then the tube contents was shaken vigorously. Fifteen ml of diethylether:hexane (1:1) was added to the tube and it was shaken again. When the layers separated, the upper layer was pipetted into a Kuderna-Danish evaporator. The extraction was repeated twice more and the combined extract was concentrated to 1.0 ml. A 0.1-ml aliquot of the extract was removed for gravimetric measurement of percent lipid. The remaining extract was processed as per tissue analysis.
The samples were analyzed on a Hewlett-Packard 5890 GC equipped with a Ni-63 electron capture detector, using a fused silica column with a crosslinked 5% phenylmethylsilicone coating (0.33-m film thickness, 0.25-mm internal diameter Hewlett-Packard ultra II). The oven temperature was held at 100°C for 2 min, then raised up to 160°C at 10°C/min, then 1°C/min to 190°C, then 2°C/min to a final temperature of 270°C. The temperature was held at 270°C for 10 min until all congeners were eluted. Ninety-six PCB congeners were identified and measured. The microprocessor of the GC was calibrated with a mix of Aroclors 1221, 1016, 1254 and 1260 (200 ng/ml of each) fortified with HCB, DDE and mirex at 5, 10, and 10 ng/ml, respectively, and with 3,3Ј,4,4Ј-tetrachlorobiphenyl at 20 ng/ml. This mixture was previously characterized (Bush et al., 1985; Frame, 1996) . The data analysis was carried out with a personal computer using FILESERVER to transfer the data into a LOTUS 1 2 3 spreadsheet (Lotus Development Corp., Cambridge, MA). Quality control for the PCB analysis has been described previously (Bush et al., 1983; . Briefly, the sample was spiked with DDE as a retention-time standard before extraction. Extraction efficiency was between 85 and 90% as described in 1989, and also as determined during ongoing toxicological analysis carried out in the laboratory. Serum analysis was quality controlled according to the New York State Clinical Laboratory Evaluation Program for human serum, which was administered by the laboratory while the data presented here was produced. Duplicate liver samples were analyzed from dog 57; the major congeners were replicated to within 5% (liver) and 11% (serum). A replicate of a single sample was examined every 20 samples to ensure the consistency of the sample extraction. The average minimum detection level ( p ϭ 0.05 that the reported level is zero, Type I error) for a sample weighing 1 g was 0.02 ng/g (EPA, 1984) . It should be noted that at one quarter of this value, the chance that the congeners are present is Ͼ87% (Type II error).
Statistics. Data for enzyme activities were analyzed by the Mann Whitney U-Test using the Minitab Statistical Software package (Ryan et al., 1985) . Student's t-test was used as noted.
In an attempt to associate P450 induction with observed PCB concentrations at the congener level, the Biomedical Statistics Package (BMDP-81) was employed. Hepatic levels of each PCB congener were regressed against activities of EROD and PROD and regression coefficients were calculated for each. The regression statistics for each congener that had regression coefficients discernibly different from zero were used to calculate EROD and PROD values for each dog. Calculated EROD and PROD values were then regressed against observed values (Bush et al., 1986) . Table 1 summarizes data on enzyme activities and total PCB levels in each dog. In dogs dosed with PCBs, the PCB concentration in serum (6.0 Ϯ 5.6) and liver (98.2 Ϯ 60.4) were significantly higher than PCB concentration in serum (0.26 Ϯ 0.37, p ϭ 0.06) and liver (8.2 Ϯ 1.2, p ϭ 0.03) in controls (mean Ϯ standard deviation, Student's t-test). Hepatic levels never exceeded 10 ppb in control dogs, and most had no detectable serum PCBs (detection limit 0.5 ppb). This clearly demonstrated hepatic accumulation of PCBs in the dosed animals.
RESULTS
Immunoblotting was used to examine the relative concentrations of specific P450 isoforms in the livers of dogs. Figure  1A shows bands representing immunoreactive CYP1A1 and CYP1A2, while Figure 1B shows CYP2B1 and CYP2B2 in dogs exposed to two concentrations of dietary PCBs. Identification of the bands was based on the relative position of the two isoforms as in rats. The polyclonal antisera against rat CYP1A1 and CYP1A2 clearly identified two bands (Fig. 1A) in immunoblots of canine liver microsomes. The top band, CYP1A1, had an apparent molecular weight of 54 kDa. The lower band was canine CYP1A2. Polyclonal anti-rat CYP2B antisera identified two bands (50 and 51 kDa). A third protein (75 kDa) that immunoreacts with the anti-CYP2B antisera was larger than any reported P450 enzyme and is unlikely to represent a CYP2B family enzyme. This band was also induced in the PCB exposed dogs (Fig. 1B) . The bands representing the rat P450s resulted in a large major band, because the rat antibody has higher affinity for the rat proteins. Densitometric analyses showed clear differences in CYP1A1 concentration between control and all PCB-exposed dogs; similar analyses of 2B1 concentrations demonstrated differences only between controls and dogs exposed to 25 ppm PCB (Fig. 2 ). CYP1A2 and CYP2B2 had similar patterns of induction as CYP1A1 and CYP2B1, respectively (data not shown). There was a positive linear correlation between EROD activity and the relative intensity of immunoreactive CYP1A1 (r 2 ϭ 0.730; Fig. 3 ). No similar correlation existed between PROD activity and the relative intensity of immunoreactive CYP2B1. These data showed clearly that CYP1A1 is induced by PCB exposure and that CYP1A1 levels correlated well with EROD activities.
To understand better the influence of PCB exposure on P450 activities, the data were further analyzed to examine P450 activities in the different dose groups (listed in Table 1 ). Control dogs from this study had EROD and PROD activities similar to those published previously for non-induced dogs which were 11-14 pmol/min/mg protein for EROD activity (Jayyosi et al., 1996) and 44 -52 pmol/min/mg protein for PROD activity (Jayyosi et al., 1996; Shimada et al., 1997) .
EROD activity is significantly elevated above controls levels (65 Ϯ 28) in all exposed dogs (222 Ϯ 55, mean Ϯ standard deviation, Student's t-test, p Ͻ 0.001); however, there is no significant group difference between dogs receiving 5 or 25 ppm PCB or between male and female dogs within the same dose group. While dogs exposed to PCB had higher mean levels of PROD activity, only female dogs exposed to 5 ppm PCB had significantly elevated PROD activity relative to controls. This statistical significance is influenced by the unusually high PROD activity of a single dog (dog 53, Table 1 ). The large variability in PROD activity and the small sample size may have influenced the statistical significance of PROD activity between these groups. These data showed clearly that EROD activity was induced by PCB exposure while induction of CYP2B enzymes and PROD activity was less evident.
To determine the effects of PCB concentration in serum and liver on the induction of EROD activity, we compared EROD activity from each dog to its corresponding PCB level in serum and liver. Dogs with greater than 1 ppb serum PCB had maximal EROD activities (Fig. 4) . Dogs exposed to 25 ppm PCB for 10 weeks, followed by 10 weeks without exposure, had sub-maximal EROD activities (Table 1) . EROD activities could be a useful indicator of PCB concentrations in serum when PCB exposure is low. However, maximal levels of EROD activity may not provide useful information regarding the PCB burden in serum, because the maximal EROD induction occurs in a wide range of PCB concentrations in serum. When EROD activity is plotted against liver PCB concentration in control dogs and those exposed to 5 ppm PCB, the response maximizes then declines in exposed dogs with high levels of PCB in the liver (Fig. 5) . The small number of dogs with high liver levels of PCB have sub-maximal induction of EROD activity. This data indicates that EROD activities may not be useful for accurately estimating PCB concentrations in liver.
To explain further the inverse relationship between high hepatic PCB concentrations and EROD activity, we examined the PCB congener profile for liver samples from 2 male and 2 female dogs from the control and 5 ppm dose groups in addition to the two male dogs from the 25 ppm dose group (Table 2) . In three dogs from the 5 ppm dose group (52, 57, and 58), only a small subset of congeners (IUPAC # 47 ϩ 59, 74, 85, 94, 99, 138 ϩ 163, 153, and 180) contributed to most of the liver concentrations of PCB in each dog. However, the dog with the highest PCB concentration in the liver (dog 51) was strikingly different from other dogs. Seventy-eight percent of the total liver PCBs in this animal was composed of 7 congeners, which were either not retained or were minor components of hepatic PCBs in other dogs. These congeners are IUPAC # 4, 18, 28, 44, 52, 87, and 90; all except one is a diorthosubstituted congener. These congeners should induce CYP1A and CYP2B enzymes in normal dogs receiving PCB. Furthermore, when scatter plots of the PCB congeners from dogs 51, 52, 57, 58, C3, and C4 were produced, dog by dog, against dog 57, (after log transformation to allow the low level congeners to become visible), five of the dogs were correlated with an r 2 Ͼ 0.8. Dog 51 was clearly an outlier (data not shown). It is not known if accumulation in this dog indicates an inability to biotransform these congeners due to low induction of P450s, or that the levels of the PCBs over 20 weeks overwhelmed the microsomal oxidase system in this dog. Alternatively, this dog could have been exposed to PCBs prior to this study.
Since not all congeners from the dose, a mixture of PCBs, are likely inducers of EROD and PROD activity, we attempted to discern which individual congeners contribute most to the P450 induction. To complete this analysis, the following linear model was applied to the data set:
Now, partial differentiation gives:
where y is EROD or PROD activity, x i is the i th PCB congener in the liver and b i is the slope of the regression of the EROD or PROD activity vs. each PCB congener concentration. Due to the odd disposition of PCBs in dog 51, data from this animal is not included in this data set. Table 3 shows the regression statistics of congeners with regression coefficients discernibly different from zero ( p Ͻ 0.05). The r 2 for all 4 congeners was Ͼ 0.3. When these statistics were used to calculate PROD and EROD values for each dog and then regressed against the observed values, a strong correlation was found. The relatively high r 2 for these correlations, 0.48 and 0.50 for PROD and EROD respectively, indicates that the model has considerable merit, predicting 50% of the total variance in the experiment. Table 3 shows that a relatively small subset of PCBs have unusually strong influence on the induction of the two enzy- matic activities. Clearly, 2, 5, 2Ј, 5Ј-tetrachlorobiphenyl and the semicoplanar 2, 4, 5, 3Ј, 4Ј-pentachlorobiphenyl (IUPAC numbers 52 and 118) have the greatest influence on the induction of EROD and PROD activities. PCB 118 is a known inducer of CYP1A1 (Lorenzen et al., 1997; Newstead et al., 1995; Skaare et al., 1991) . This exemplifies the utility of carrying out preliminary toxicological experiments with mixtures, using simple modeling to evaluate the results. This method was previously applied using a statistical package (BMDP) on liver function assays in rats (P450 and aniline hydroxylase) and on sperm function in men (Bush et al., 1986) . This is the first application of this approach to liver function and PCB congeners in dogs. A comparison of PCB profiles between the serum and liver samples showed that different congeners are sequestered to different tissues. Few highly chlorinated congeners were found in serum of dogs dosed with 5 ppm PCB (data not shown); however, 58% of total hepatic PCBs are composed of pentachlorinated species or higher, including 2,4,5,2Ј,4Ј,5Ј-hexachlorobiphenyl and 2,3,4,5,2Ј4Ј5Ј-heptachlorobiphenyl. Prominent among these were congeners IUPAC numbers 99, 153, 170, and 180. A similar profile was seen in dogs exposed for 10 weeks to 25 ppm PCB. In these dogs a higher proportion of the total hepatic accumulation involved highly chlorinated congeners (77%). This indicated that a small number of highly chlorinated congeners were the predominant forms sequestered to the liver.
To characterize the effects of fasting on the PCB burden in serum, two dogs in group C (25 ppm dose for 10 weeks) were fasted for 48 h in week 12. New congeners appeared in the serum within 24 h of fasting (Table 4) . Congeners (IUPAC numbers) 52, 118, 128, 137, and 138 entered the circulation at 24 h and remained during the 48 h of fasting. Congener 164 entered the circulation only after 48 h of fasting. These observations were similar in the two fasting dogs. Concomitant with the appearance of new congeners, the serum PCB concentration increased from 7.79 to 22.9 ppb (293%) by 24 h. This increase indicated that high levels of PCB may mobilize into the serum during fasting.
DISCUSSION
We examined the utility of induction of cytochromes P450 as biomarkers of PCB exposure in domestic dogs. Several researchers propose the use of induction of CYP1A1 and EROD activity by PCBs as biomarkers of exposure to PCB (Lindstrom-Seppa et al., 1994; Rattner et al., 1993; White et al., 1994; Yawetz et al., 1997) . In support of this monitoring method, our results showed clear induction of CYP1A1 and EROD activity in all dogs exposed to PCB's (Figs. 1, 2, 4 , and 5). Generally, elevated EROD activities were obvious in exposed dogs. The strong correlation between EROD activity and relative levels of CYP1A1 demonstrated that EROD activity is a good indication of CYP1A1 expression in dogs. Furthermore, the dogs in group C retained relatively high levels of EROD activity 10 weeks after the final dose of PCB. This indicates that EROD activity could also reflect prior exposure to PCBs.
However, EROD activity was not a good indicator for the extent of exposure. When EROD activity was plotted against serum PCB concentration (Fig. 4) , dogs with Ͼ1 ppb serum PCB appeared to have maximum induction of EROD activity which was 250 -300% above control levels. Dogs with a range of PCB concentration from 1 to 9 ppb in serum did not have a concurrent increase in EROD activity. This indicates that EROD activity may not be an accurate indication of the extent of PCB concentration in serum at high levels of PCB contam- ination. A different induction pattern was observed when EROD activity was compared to PCB levels in liver. EROD activity was inversely correlated to hepatic PCB concentration at high levels of hepatic PCB (Fig. 5) . This pattern was observed previously in hepatocytes exposed to PCBs, 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran (Lorenzen et al., 1997; Verhallen et al., 1997) . Although this pattern of reduced EROD activity is not yet understood, this may be explained by competition between congeners known to induce CYP1A1 enzymes and those known to inhibit induction (Schmoldt et al., 1977; WHO, 1993) . Alternatively, high levels of PCB may cause a post-transcriptional suppression of CYP1A1 as found in fish (White et al., 1997) . In our study, one dog (#51) with the greatest hepatic PCB concentration had low EROD activity and low PROD activity, but accumulated large concentrations of diortho-substituted congeners, or "mixed" inducers. Their accumulation in this instance may represent a failure of microsomal enzymes to biotransform them, or inadvertent exposure to PCBs prior to entry in this study.
We conclude that induction of cytochromes P450 in domestic dogs may not be the best biomarker of PCB contamination. Induction of CYP1A1 and EROD activity was obvious in all dogs exposed to PCBs, but the EROD levels did not accurately reflect the PCB concentrations in liver or serum. Furthermore, liver samples from domestic dogs may be difficult to obtain. However, P450 induction in other species, particularly fish and other wildlife, may remain a viable biomarker for PCB contamination. Eighteen other assays were performed on these dogs during week 16 of this experiment to identify good biomarkers of environmental exposure to PCBs. Data regarding these assays were presented in different forums (Cohen et al., 1997; Fadden et al., 1997) . These other assays showed that both dose groups had increased blood neutrophil counts and tear flow, but had remarkable decreases of IgM, IgA, and total thyroxine in serum. In addition, exposed male dogs had decreased serum prolactin and testosterone and decreased sperm count. Several of these non-invasive assays, including serum PCB level, may adequately detect PCB exposure in domestic dogs and act as biomarkers of PCB contamination at Akwesasne.
A small subset of congeners in liver correlated best with the induction of EROD and PROD activities; these few compounds may be the major cause of induction. This indicates that only a few congeners may be responsible for most of the enzyme induction and that exposure to the majority of the congeners may not cause induction. Further confirmation is required to verify that this subset of congeners is the primary source of CYP1A1 induction in dogs.
PCB concentration in serum remains the most straightforward indicator of exposure to PCBs. Shilling et. al. (1998) proposed using PCB concentration in dog serum as a marker of PCB exposure. Our data supports this proposal. All dogs exposed to PCB in our study had higher concentrations of serum PCB. We found statistically significant increases in serum PCB concentration after only 1 week of exposure (40-fold increase in dogs exposed to 25 ppm) and the serum congener profile was composed of lower chlorinated species (5 chlorine residues or less). Between weeks 2 and 10, the PCB concentration continued to increase (although at a much slower rate) and a small number of more heavily chlorinated species appeared (unpublished data). In this group (25 ppm), serum concentrations of PCB decreased only 18% by week 20 in dogs that were only dosed during the first 10 weeks. The serum concentrations in these dogs were still as high as dogs continuously dosed at 5 ppm PCB. This slow elimination of PCBs, especially highly chlorinated congeners, was reported previously in a variety of species including dogs (Sipes and Schnellmann, 1987) .
Our studies in the PCB profiles in these dogs contradict previous reports regarding PCB metabolism in dogs. Unlike previous reports demonstrating rapid elimination of 2,4,5,2Ј,4Ј,5Ј-hexachlorobiphenyl in dogs (Duignan et al., 1987; Sipes et al., 1982) , our dogs retained high serum and liver concentrations of this congener (IUPAC #153, Table 2 ). The difference between our data and the results of Sipes, et al. (1982) may result from different dosing methods; the in vivo metabolism of 2,4,5,2Ј,4Ј,5Ј-hexachlorobiphenyl was measured after a single intravenous injection of 2,4,5,2Ј,4Ј,5Ј-hexachlorobiphenyl (Sipes et al., 1982) as opposed to chronic exposure in our study. Duignan et al. (1987) examined 2,4,5,2Ј,4Ј,5Ј-hexachlorobiphenyl metabolism in dogs induced with phenobarbital. Since the phenobarbital inducible P450 enzymes (CYP2B family) are known to metabolize this congener in dogs (Ariyoshi et al., 1992; Duignan et al., 1988) , the minimal CYP2B induction seen in many of our PCB-exposed dogs may explain the persistence of this congener. Whether the chronic exposure paradigm used in this study is responsible for the low CYP2B induction is unknown, but worthy of further investigation given the potential adverse sequelae which could arise in animals or humans incapable of normal CYP2B enzyme induction.
Other congeners accumulating in the liver include IUPAC 170 and 180 (Table 2) , which were identified as persistent (non-metabolized) congeners in wildlife (WHO, 1993) and among the most toxic (toxic equivalency factor) of the highly chlorinated congeners (Kafafi et al., 1993) . The skewed proportion of highly chlorinated congeners present in liver is also consistent with previous observations in other animals (WHO, 1993) .
Finally, we demonstrate that lipophilic congeners absent in blood enter the circulation during fasting (Table 4) . Food withdrawal for only 24 h was associated with a 293% increase in serum PCB concentration and with the appearance of 14 new congeners, all but 2 of which have 5 or more chlorine substitutions. One congener (IUPAC 164) entered the circulation after 48 h of fasting. This rapid redistribution of highly chlorinated biphenyls was unexpected and may have profound implications in wildlife, where long periods of fasting accom-pany certain natural life-cycle events, e.g., migration, hibernation.
